Of note, plasma levels of VEGF-A were higher in patients with PAH, CTEPH, and PH-LHD compared to controls, although some controversy exists regarding the presence or absence of significant differences in VEGF-A between PH etiologies (71, 72). The gene discussed is VEGFA; the disease is chronic thromboembolic pulmonary hypertension.